Detalles de la búsqueda
1.
Successful treatment of refractory secondary immune thrombocytopenia (antiphospholipid antibody syndrome-associated) with the combination of rituximab and romiplostim at the cost of severe bone pain: A case report and review of literature.
J Oncol Pharm Pract
; 27(1): 253-257, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32611269
2.
Hybrid Capture-Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well-Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing.
Oncologist
; 23(7): 776-781, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29540602
3.
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors.
Lung Cancer (Auckl)
; 11: 33-39, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32368168
4.
Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer.
Case Rep Oncol
; 7(1): 252-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24847251
5.
A Near-Complete Response to Treatment with Gemcitabine plus nab (®)-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report.
Case Rep Oncol
; 7(3): 711-7, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25493084
Resultados
1 -
5
de 5
1
Próxima >
>>